Electromed (ELMD) vs InMode (INMD)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Electromed (ELMD) has outperformed InMode (INMD) over the past year, gaining 14.4% versus a loss of 6.8%. Over five years, ELMD leads with a +156.6% price change compared with -83.2% for INMD. InMode is the larger company by market cap ($810.2 million vs $230.4 million), about 3.5 times the size.
On valuation, InMode trades at a lower forward P/E (10.3x vs 45.6x for Electromed).
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ELMD | INMD |
|---|---|---|
| Share price | $27.80 | $14.08 |
| Market cap | $230.38M | $810.22M |
| 1-day change | -1.42% | +0.50% |
| YTD return | -3.16% | -4.63% |
| 1-year return | +14.45% | -6.79% |
| 5-year return | +156.60% | -83.20% |
| P/E ratio (TTM) | 21.38 | 11.64 |
| Forward P/E | 45.57 | 10.26 |
| EPS (TTM) | $1.30 | $1.21 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $47.40 | $16.74 |
| 52-week low | $23.01 | $12.72 |
| Distance from 52-week high | -41.35% | -15.89% |
| Analyst consensus | none | none |
| Avg. price target upside | +74.46% | +14.84% |
| Average volume | 104.76K | 521.98K |
| Shares outstanding | 8.29M | 57.54M |
| Employees | 195 | 660 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- InMode is about 3.5 times larger than Electromed by market value ($810.22M vs $230.38M).
- ELMD has outperformed INMD by 21.2 percentage points over the past year.
- Electromed trades at a higher earnings multiple (21.4x vs 11.6x trailing P/E).
About Electromed
ELMD stock →Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients in the United States and internationally.
Health Care · Biotechnology: Electromedical & Electrotherapeutic Apparatus · 195 employees
About InMode
INMD stock →InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radio frequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States, Europe, Asia, and internationally.
Health Care · Biotechnology: Electromedical & Electrotherapeutic Apparatus · 660 employees
ELMD vs INMD FAQ
Which is bigger, Electromed or InMode?
InMode (INMD) is larger, with a market capitalization of $810.22M compared with $230.38M for Electromed (ELMD).
Which stock has performed better over the past year, ELMD or INMD?
ELMD returned +14.45% over the past 12 months, compared with -6.79% for INMD (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, ELMD or INMD?
INMD has the lower trailing P/E at 11.6, versus 21.4 for ELMD. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Are Electromed and InMode in the same industry?
Yes. Both are classified in the Biotechnology: Electromedical & Electrotherapeutic Apparatus industry within the Health Care sector.